125 related articles for article (PubMed ID: 1819624)
1. Restoration of immune functions after chemotherapy.
Seminara P; Afeltra A; Codacci Pisanelli M; Aronne T; Franchi F
J Chemother; 1991 Dec; 3(6):390-1. PubMed ID: 1819624
[TBL] [Abstract][Full Text] [Related]
2. [50-year-old man with weight loss and splenomegaly].
Austein T; Schmitt A
Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
[No Abstract] [Full Text] [Related]
3. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
4. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
Lichtman SM; Wasil T; Ahmad M; Brody J
Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
[TBL] [Abstract][Full Text] [Related]
5. Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
Clavio M; Masoudi B; Spriano M; Casciaro S; Gobbi M; Damasio EE
Haematologica; 1999 May; 84(5):466-8. PubMed ID: 10329930
[No Abstract] [Full Text] [Related]
6. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
Al-Fiar F; Meharchand J; Curtis J; Lipton JH
Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
[TBL] [Abstract][Full Text] [Related]
7. Alpha interferon in the treatment of hairy cell leukemia.
Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
[No Abstract] [Full Text] [Related]
8. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
Gómez-Almaguer D; Jaime-Pérez JC; Herrera-Garza JL; González-Llano O
Rev Invest Clin; 1998; 50(4):331-4. PubMed ID: 9830322
[TBL] [Abstract][Full Text] [Related]
9. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.
Buckstein R; Patel H; Chesney A; Reis M; Imrie K
Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666
[TBL] [Abstract][Full Text] [Related]
10. Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia.
Benz R; Stussi G; Fehr J
Br J Haematol; 2010 Feb; 148(4):664-5; author reply 665-6. PubMed ID: 19814738
[No Abstract] [Full Text] [Related]
11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
12. Atypical mycobacterial infection in a patient with hairy cell leukemia.
Trizna Z; Tschen J; Natelson EA
Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
[TBL] [Abstract][Full Text] [Related]
13. Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
Urosevic-Maiwald M; Nobbe S; Kerl K; Benz R
J Dermatol; 2014 Apr; 41(4):329-33. PubMed ID: 24612373
[TBL] [Abstract][Full Text] [Related]
14. [Hairy cell leukemia: therapeutic approaches].
Paitel JF; Guerci A; Lederlin P
Rev Med Interne; 1996; 17(5):399-406. PubMed ID: 8763100
[TBL] [Abstract][Full Text] [Related]
15. Reversible cardiomyopathy in a patient with hairy cell leukaemia.
Sucak GT; Haznedar R; Yalçin R
Postgrad Med J; 1998 May; 74(871):313-4. PubMed ID: 9713625
[No Abstract] [Full Text] [Related]
16. Clinical relevance of recombinant interferon-alpha 2a antibodies in patients with hairy cell leukemia.
Steis RG; Longo DL
J Interferon Res; 1994 Aug; 14(4):207-9. PubMed ID: 7822877
[No Abstract] [Full Text] [Related]
17. Hairy cell leukemia: treatment successes in the past 25 years.
Golomb HM
J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
[No Abstract] [Full Text] [Related]
18. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
19. Is therapy with cytostatics obsolete in hairy-cell leukemia?
Franchi F; Seminara P; Codacci-Pisanelli G; Bianco P
Int J Clin Lab Res; 1992; 22(2):122-3. PubMed ID: 1504306
[No Abstract] [Full Text] [Related]
20. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
